University of Colorado Boulder
Boulder, Colorado, 80303, United States
NCT Number: NCT02550925
This randomized clinical trial compares group acceptance and commitment therapy (ACT) to usual care for cancer survivors experiencing anxiety following the end of cancer treatment.
Looking for future studies?
Notify MeHealthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
A 7-session Acceptance and Commitment Therapy (ACT) group intervention
Check in with clinical social worker at oncology care site and obtain list of supportive resources
Time frame: Baseline to Post and (3- and 6-month) Follow Up
Method of assessment: questionnaire
Time frame: Baseline to Post and (3- and 6-month) Follow Up
Method of assessment: questionnaire
Time frame: Baseline to Post and (3- and 6-month) Follow Up
Method of assessment: survey of medical care use
Time frame: Baseline to Post and (3- and 6-month) Follow Up
Method of assessment: questionnaire
Time frame: Baseline to Post and (3- and 6-month) Follow Up
Method of assessment: questionnaire
Time frame: Baseline to Post and (3- and 6-month) Follow Up
Method of assessment: questionnaire
Time frame: Baseline to Post and 6-month Follow Up
Method of assessment: diagnostic interview
University of Colorado, Boulder
Other
A Novel Acceptance-Based Intervention for Anxious Cancer Survivors
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01498276
Cancer, Cardiovascular Diseases
Washington D.C., District of Columbia, United States
View Trial DetailsNCT04746859
Cancer, Chronic Disease
Barrie, Ontario, Canada
View Trial DetailsNCT02517281
Cancer, Neoplasms
Villejuif, Val de Marne, France
View Trial DetailsNCT00180869
Cancer, Neoplasms
Villejuif, France
View Trial Details